Literature DB >> 19203800

Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.

Sofiyan Saleem1, Yun Tai Kim, Takayuki Maruyama, Shuh Narumiya, Sylvain Doré.   

Abstract

Ischemic stroke is one of the leading causes of mortality and morbidity in humans. During brain ischemia and the subsequent reperfusion that occurs with stroke, the generation of the so-called "proinflammatory" prostaglandin E(2) (PGE(2)) increases significantly. Therefore, interest is growing regarding the differential functions of the individual PGE(2) receptors (EP1-4) and their relative contribution to brain damage following ischemic and inflammatory stimuli. Here, we address the contribution of the EP3 receptor in dictating early outcomes after transient cerebral ischemia. An oxygen-glucose deprivation (OGD)-induced in vitro model of brain ischemia was used in mouse hippocampal slice cultures. For transient ischemia, the right middle cerebral artery (MCA) of wildtype (WT) and EP3 knockout (EP3(-/-)) C57BL/6 male mice was occluded for 90 min and reperfused for 48 or 96 h, after which neurobehavioral scores and infarct volumes were determined. Mean arterial blood pressure, pH, blood gases (PaO(2) and PaCO(2)), cerebral blood flow, and body temperature were also determined before and during ischemia and reperfusion. OGD-induced cell death was significantly lower in brain slice cultures of EP3(-/-) mice than in those of WT mice. EP3(-/-) mice that underwent transient ischemia had significantly smaller infarct volumes than did WT mice at 48 h, but this difference was not sustained at 96 h. Neurological score deficits correlated with infarct volume, but no significant differences in the physiological parameters monitored were detected between the two genotypes. The results further support a role for EP3 receptors in contributing to acute ischemic stroke, but EP3 is not likely the sole contributor to the long-term detrimental consequences of PGE(2).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19203800      PMCID: PMC2713583          DOI: 10.1016/j.jneuroim.2009.01.015

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  51 in total

1.  Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury.

Authors:  Melanie Martin; Jutta Meyer-Kirchrath; Gernot Kaber; Christoph Jacoby; Ulrich Flögel; Jürgen Schrader; Ulrich Rüther; Karsten Schrör; Thomas Hohlfeld
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

2.  Molecular evolution of receptors for eicosanoids.

Authors:  H Toh; A Ichikawa; S Narumiya
Journal:  FEBS Lett       Date:  1995-03-13       Impact factor: 4.124

Review 3.  The role of prostaglandins and other eicosanoids in the gastrointestinal tract.

Authors:  Dingzhi Wang; Jason R Mann; Raymond N DuBois
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

4.  EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.

Authors:  Vikram Jadhav; Anthony Jabre; Shinn-Zong Lin; Tony Jer-Fu Lee
Journal:  J Cereb Blood Flow Metab       Date:  2004-12       Impact factor: 6.200

5.  Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender.

Authors:  Xiaoling Li; Kathleen K Blizzard; Zhiyuan Zeng; A Courtney DeVries; Patricia D Hurn; Louise D McCullough
Journal:  Exp Neurol       Date:  2004-05       Impact factor: 5.330

6.  Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.

Authors:  Jun Li; Xibin Liang; Qian Wang; Richard M Breyer; Louise McCullough; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2008-04-20       Impact factor: 3.046

7.  Mouse prostaglandin E receptor EP3 subtype mediates calcium signals via Gi in cDNA-transfected Chinese hamster ovary cells.

Authors:  A Irie; E Segi; Y Sugimoto; A Ichikawa; M Negishi
Journal:  Biochem Biophys Res Commun       Date:  1994-10-14       Impact factor: 3.575

8.  Postconditioning with isoflurane reduced ischemia-induced brain injury in rats.

Authors:  Jeong Jin Lee; Liaoliao Li; Hae-Hyuk Jung; Zhiyi Zuo
Journal:  Anesthesiology       Date:  2008-06       Impact factor: 7.892

9.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

10.  Isoforms of the EP3 subtype of human prostaglandin E2 receptor transduce both intracellular calcium and cAMP signals.

Authors:  S An; J Yang; S W So; L Zeng; E J Goetzl
Journal:  Biochemistry       Date:  1994-12-06       Impact factor: 3.162

View more
  29 in total

1.  Inflammation after stroke: mechanisms and therapeutic approaches.

Authors:  Muzamil Ahmad; Steven H Graham
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

2.  Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease.

Authors:  Uzma Chaudhry; Hean Zhuang; Sylvain Doré
Journal:  Exp Neurol       Date:  2009-08-05       Impact factor: 5.330

3.  Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.

Authors:  Doina Ganea; Virginia Kocieda; Weimin Kong; Jui-Hung Yen
Journal:  Clin Lipidol       Date:  2011-06

4.  Genetic deletion of the prostaglandin E2 E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhage.

Authors:  Jenna L Leclerc; Andrew S Lampert; Matthew A Diller; Sylvain Doré
Journal:  Eur J Neurosci       Date:  2015-05       Impact factor: 3.386

5.  Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors.

Authors:  Y Ikeda-Matsuo; H Tanji; A Ota; Y Hirayama; S Uematsu; S Akira; Y Sasaki
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

6.  Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity.

Authors:  Yun Tai Kim; Sang Kwan Moon; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurobiol Dis       Date:  2012-06-16       Impact factor: 5.996

7.  PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old mice.

Authors:  Jenna L Leclerc; Andrew S Lampert; Matthew A Diller; Sylvain Doré
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-15       Impact factor: 4.733

8.  Death-associated protein kinase-mediated cell death modulated by interaction with DANGER.

Authors:  Bingnan N Kang; Abdullah S Ahmad; Sofiyan Saleem; Randen L Patterson; Lynda Hester; Sylvain Doré; Solomon H Snyder
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

9.  The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke.

Authors:  Muzamil Ahmad; Sofiyan Saleem; Zahoor Shah; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Exp Transl Stroke Med       Date:  2010-07-08

Review 10.  Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.

Authors:  Hui Huang; Mohamed Al-Shabrawey; Mong-Heng Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-12-30       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.